Guyana vs Landlocked developing countries (LLDCs): Proportion of the target population who received a 3rd dose of
Guyana
98.0%
in 2024
Landlocked developing countries (LLDCs)
76.0%
in 2024
Guyana rank
7th
Landlocked developing countries (LLDCs) rank
8th
Proportion of the target population who received a 3rd dose of over time
- Guyana
- Landlocked developing countries (LLDCs)
How they compare
Guyana currently reports 98.0% against 76.0% in Landlocked developing countries (LLDCs), a difference of 22.0%.
That makes Guyana's figure about 1.3 times Landlocked developing countries (LLDCs)'s.
Across all 14 years both countries report, Guyana has been ahead every year.
Guyana ranks 7th and Landlocked developing countries (LLDCs) ranks 8th of 136 countries.
Guyana has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guyana | Landlocked developing countries (LLDCs) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 89.4% | 48.7% | 40.8% | Guyana |
| 2020s | 95.8% | 72.2% | 23.6% | Guyana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Guyana or Landlocked developing countries (LLDCs)?
- Guyana, at 98.0% against 76.0% in Landlocked developing countries (LLDCs) as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Guyana and Landlocked developing countries (LLDCs)?
- 22.0%, with Guyana ahead.
- How many years of comparable data are there for Guyana and Landlocked developing countries (LLDCs)?
- 14 years are reported by both, from 2011 to 2024.
- How do Guyana and Landlocked developing countries (LLDCs) rank globally for proportion of the target population who received a 3rd dose of?
- Guyana ranks 7th and Landlocked developing countries (LLDCs) ranks 8th of 136 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.